A benchmarking method to evaluate the accuracy of a commercial proton monte carlo pencil beam scanning treatment planning system

Liyong Lin, Sheng Huang, Minglei Kang, Petri Hiltunen, Reynald Vanderstraeten, Jari Lindberg, Sami Siljamaki, Todd Wareing, Ian Davis, Allen Barnett, John Mcghee, Charles B. Simone, Timothy D. Solberg, James E. Mcdonough, Christopher Ainsley

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

AcurosPT is a Monte Carlo algorithm in the Eclipse 13.7 treatment planning system, which is designed to provide rapid and accurate dose calculations for proton therapy. Computational run-time in minimized by simplifying or eliminating less significant physics processes. In this article, the accuracy of AcurosPT was benchmarked against both measurement and an independent MC calculation, TOPAS. Such a method can be applied to any new MC calculation for the detection of potential inaccuracies. To validate multiple Coulomb scattering (MCS) which affects primary beam broadening, single spot profiles in a Solidwater® phantom were compared for beams of five selected proton energies between AcurosPT, measurement and TOPAS. The spot Gaussian sigma in AcurosPT was found to increase faster with depth than both measurement and TOPAS, suggesting that the MCS algorithm in AcurosPT overestimates the scattering effect. To validate AcurosPT modeling of the halo component beyond primary beam broadening, field size factors (FSF) were compared for multi-spot profiles measured in a water phantom. The FSF for small field sizes were found to disagree with measurement, with the disagreement increasing with depth. Conversely, TOPAS simulations of the same FSF consistently agreed with measurement to within 1.5%. The disagreement in absolute dose between AcurosPT and measurement was smaller than 2% at the mid-range depth of multi-energy beams. While AcurosPT calculates acceptable dose distributions for typical clinical beams, users are cautioned of potentially larger errors at distal depths due to overestimated MCS and halo implementation.

Original languageEnglish (US)
Pages (from-to)44-49
Number of pages6
JournalJournal of Applied Clinical Medical Physics
Volume18
Issue number2
DOIs
StatePublished - Mar 1 2017

Fingerprint

pencil beams
Benchmarking
planning
Protons
Proton Therapy
Hospital Distribution Systems
Scanning
Planning
scanning
protons
Physics
Scattering
scattering
dosage
Water
halos
Therapeutics
eclipses
profiles
proton energy

Keywords

  • AcurosPT
  • Commissioning
  • Monte Carlo dose calculation
  • Pencil beam scanning
  • Proton therapy

ASJC Scopus subject areas

  • Radiation
  • Instrumentation
  • Radiology Nuclear Medicine and imaging

Cite this

A benchmarking method to evaluate the accuracy of a commercial proton monte carlo pencil beam scanning treatment planning system. / Lin, Liyong; Huang, Sheng; Kang, Minglei; Hiltunen, Petri; Vanderstraeten, Reynald; Lindberg, Jari; Siljamaki, Sami; Wareing, Todd; Davis, Ian; Barnett, Allen; Mcghee, John; Simone, Charles B.; Solberg, Timothy D.; Mcdonough, James E.; Ainsley, Christopher.

In: Journal of Applied Clinical Medical Physics, Vol. 18, No. 2, 01.03.2017, p. 44-49.

Research output: Contribution to journalArticle

Lin, L, Huang, S, Kang, M, Hiltunen, P, Vanderstraeten, R, Lindberg, J, Siljamaki, S, Wareing, T, Davis, I, Barnett, A, Mcghee, J, Simone, CB, Solberg, TD, Mcdonough, JE & Ainsley, C 2017, 'A benchmarking method to evaluate the accuracy of a commercial proton monte carlo pencil beam scanning treatment planning system', Journal of Applied Clinical Medical Physics, vol. 18, no. 2, pp. 44-49. https://doi.org/10.1002/acm2.12043
Lin, Liyong ; Huang, Sheng ; Kang, Minglei ; Hiltunen, Petri ; Vanderstraeten, Reynald ; Lindberg, Jari ; Siljamaki, Sami ; Wareing, Todd ; Davis, Ian ; Barnett, Allen ; Mcghee, John ; Simone, Charles B. ; Solberg, Timothy D. ; Mcdonough, James E. ; Ainsley, Christopher. / A benchmarking method to evaluate the accuracy of a commercial proton monte carlo pencil beam scanning treatment planning system. In: Journal of Applied Clinical Medical Physics. 2017 ; Vol. 18, No. 2. pp. 44-49.
@article{37c265560fa84a3c9e809aef66cd36f9,
title = "A benchmarking method to evaluate the accuracy of a commercial proton monte carlo pencil beam scanning treatment planning system",
abstract = "AcurosPT is a Monte Carlo algorithm in the Eclipse 13.7 treatment planning system, which is designed to provide rapid and accurate dose calculations for proton therapy. Computational run-time in minimized by simplifying or eliminating less significant physics processes. In this article, the accuracy of AcurosPT was benchmarked against both measurement and an independent MC calculation, TOPAS. Such a method can be applied to any new MC calculation for the detection of potential inaccuracies. To validate multiple Coulomb scattering (MCS) which affects primary beam broadening, single spot profiles in a Solidwater{\circledR} phantom were compared for beams of five selected proton energies between AcurosPT, measurement and TOPAS. The spot Gaussian sigma in AcurosPT was found to increase faster with depth than both measurement and TOPAS, suggesting that the MCS algorithm in AcurosPT overestimates the scattering effect. To validate AcurosPT modeling of the halo component beyond primary beam broadening, field size factors (FSF) were compared for multi-spot profiles measured in a water phantom. The FSF for small field sizes were found to disagree with measurement, with the disagreement increasing with depth. Conversely, TOPAS simulations of the same FSF consistently agreed with measurement to within 1.5{\%}. The disagreement in absolute dose between AcurosPT and measurement was smaller than 2{\%} at the mid-range depth of multi-energy beams. While AcurosPT calculates acceptable dose distributions for typical clinical beams, users are cautioned of potentially larger errors at distal depths due to overestimated MCS and halo implementation.",
keywords = "AcurosPT, Commissioning, Monte Carlo dose calculation, Pencil beam scanning, Proton therapy",
author = "Liyong Lin and Sheng Huang and Minglei Kang and Petri Hiltunen and Reynald Vanderstraeten and Jari Lindberg and Sami Siljamaki and Todd Wareing and Ian Davis and Allen Barnett and John Mcghee and Simone, {Charles B.} and Solberg, {Timothy D.} and Mcdonough, {James E.} and Christopher Ainsley",
year = "2017",
month = "3",
day = "1",
doi = "10.1002/acm2.12043",
language = "English (US)",
volume = "18",
pages = "44--49",
journal = "Journal of Applied Clinical Medical Physics",
issn = "1526-9914",
publisher = "American Institute of Physics Publising LLC",
number = "2",

}

TY - JOUR

T1 - A benchmarking method to evaluate the accuracy of a commercial proton monte carlo pencil beam scanning treatment planning system

AU - Lin, Liyong

AU - Huang, Sheng

AU - Kang, Minglei

AU - Hiltunen, Petri

AU - Vanderstraeten, Reynald

AU - Lindberg, Jari

AU - Siljamaki, Sami

AU - Wareing, Todd

AU - Davis, Ian

AU - Barnett, Allen

AU - Mcghee, John

AU - Simone, Charles B.

AU - Solberg, Timothy D.

AU - Mcdonough, James E.

AU - Ainsley, Christopher

PY - 2017/3/1

Y1 - 2017/3/1

N2 - AcurosPT is a Monte Carlo algorithm in the Eclipse 13.7 treatment planning system, which is designed to provide rapid and accurate dose calculations for proton therapy. Computational run-time in minimized by simplifying or eliminating less significant physics processes. In this article, the accuracy of AcurosPT was benchmarked against both measurement and an independent MC calculation, TOPAS. Such a method can be applied to any new MC calculation for the detection of potential inaccuracies. To validate multiple Coulomb scattering (MCS) which affects primary beam broadening, single spot profiles in a Solidwater® phantom were compared for beams of five selected proton energies between AcurosPT, measurement and TOPAS. The spot Gaussian sigma in AcurosPT was found to increase faster with depth than both measurement and TOPAS, suggesting that the MCS algorithm in AcurosPT overestimates the scattering effect. To validate AcurosPT modeling of the halo component beyond primary beam broadening, field size factors (FSF) were compared for multi-spot profiles measured in a water phantom. The FSF for small field sizes were found to disagree with measurement, with the disagreement increasing with depth. Conversely, TOPAS simulations of the same FSF consistently agreed with measurement to within 1.5%. The disagreement in absolute dose between AcurosPT and measurement was smaller than 2% at the mid-range depth of multi-energy beams. While AcurosPT calculates acceptable dose distributions for typical clinical beams, users are cautioned of potentially larger errors at distal depths due to overestimated MCS and halo implementation.

AB - AcurosPT is a Monte Carlo algorithm in the Eclipse 13.7 treatment planning system, which is designed to provide rapid and accurate dose calculations for proton therapy. Computational run-time in minimized by simplifying or eliminating less significant physics processes. In this article, the accuracy of AcurosPT was benchmarked against both measurement and an independent MC calculation, TOPAS. Such a method can be applied to any new MC calculation for the detection of potential inaccuracies. To validate multiple Coulomb scattering (MCS) which affects primary beam broadening, single spot profiles in a Solidwater® phantom were compared for beams of five selected proton energies between AcurosPT, measurement and TOPAS. The spot Gaussian sigma in AcurosPT was found to increase faster with depth than both measurement and TOPAS, suggesting that the MCS algorithm in AcurosPT overestimates the scattering effect. To validate AcurosPT modeling of the halo component beyond primary beam broadening, field size factors (FSF) were compared for multi-spot profiles measured in a water phantom. The FSF for small field sizes were found to disagree with measurement, with the disagreement increasing with depth. Conversely, TOPAS simulations of the same FSF consistently agreed with measurement to within 1.5%. The disagreement in absolute dose between AcurosPT and measurement was smaller than 2% at the mid-range depth of multi-energy beams. While AcurosPT calculates acceptable dose distributions for typical clinical beams, users are cautioned of potentially larger errors at distal depths due to overestimated MCS and halo implementation.

KW - AcurosPT

KW - Commissioning

KW - Monte Carlo dose calculation

KW - Pencil beam scanning

KW - Proton therapy

UR - http://www.scopus.com/inward/record.url?scp=85015401291&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015401291&partnerID=8YFLogxK

U2 - 10.1002/acm2.12043

DO - 10.1002/acm2.12043

M3 - Article

C2 - 28300385

AN - SCOPUS:85015401291

VL - 18

SP - 44

EP - 49

JO - Journal of Applied Clinical Medical Physics

JF - Journal of Applied Clinical Medical Physics

SN - 1526-9914

IS - 2

ER -